Neste FD vamos abordar um tema muito frequente na prática clínica: fadiga associada aos análogos do GLP-1.
Acesse a plataforma mais completa de endocrinologia: endodirect.com.br
Referencias usadas:
Nong K, Shi Q, Xie X, Wang Y, Agarwal A, Guyatt GH, et al. Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis. BMJ. 2026;394:e372161. doi:10.1136/bmj-2026-372161Nie Y, Zhang Y, Liu B, Meng H. Glucagon-like peptide-1 receptor agonists for the treatment of suboptimal initial clinical response and weight gain recurrence after bariatric surgery: a systematic review and meta-analysis. Obes Surg. 2025;35(3):808-22. doi:10.1007/s11695-025-07733-8Mohamad AA. A case report of semaglutide induced sarcopenia: causes of fatigue in older adults. Korean J Fam Med. 2025;46(4):288-91. doi:10.4082/kjfm.25.0008Eldor R, Avraham N, Rosenberg O, Shpigelman M, Golan-Cohen A, Cukierman-Yaffe T, et al. Gradual titration of semaglutide results in better treatment adherence and fewer adverse events: a randomized controlled open-label pilot study. Diabetes Care. 2025;48(9):1607-11. doi:10.2337/dc25-0690